Cisatracurium Besylate 200 mg / 20mL Injection 20 mL
Comprehensive product details for sourcing and verification.
| NDC 11 | 71288-0713-21 |
|---|---|
| Product NDC | 71288-0713 |
| Generic Drug Name | Cisatracurium Besylate |
| Brand Name | Cisatracurium Besylate |
| Manufacturer | Meitheal Pharmaceuticals Inc. |
| Strength | 200 mg / 20mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 10 Vial, Single-Dose |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-21) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-20) |
| Active Ingredients | Cisatracurium Besylate |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Cisatracurium Besylate 200 mg / 20mL Injection is tracked under NDC 71288-0713-21 and rolls up into product family 71288-0713. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 10 Vial, Single-Dose.
- Manufacturer: Meitheal Pharmaceuticals Inc..
- Dosage form: Injection.
- Family size: 2 active presentations.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby exact-item pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Documented shortage history includes two resolved cisatracurium shortage listings since 2016, a limited repeat pattern that may indicate some future supply risk.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Cisatracurium Besylate 200 mg / 20mL Injection 20 mL, NDC 71288-0713-21, is a Meitheal Pharmaceuticals Inc. 200 mg / 20mL injection presentation packaged as 10 Vial, Single-Dose. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 71288-0713-21.
- Digits-only NDC 11: 71288071321.
- Possible 10-digit display format: 71288-713-21 (7128871321).
Helpful product links
- Search by brand name: Cisatracurium Besylate.
- Exact NDC 11: 71288-0713-21.
- Product family NDC: 71288-0713.
- Compare related presentations: Cisatracurium Besylate 200 mg / 20mL Injection 20 mL.